Professor Jamshid Lotfi, M.D.

Education

1957 –1963

• The Medical College of St. Bartholomew’s Hospital, University of London, England (M. B., B. S.)  Bachelor of Medicine & Surgery (London)

• Examination of the conjoint Board of Examiners of the Royal

  College of Physicians of London and the Royal College of Surgeons of England

  (M.R.C.S.L.R.C.P.)

1965   Diploma in Child Health, (England)

(D.C.H.)

1968   Examination for the Membership of the Royal College of Physicians of London.

(M.R.C.P.) (London)

1986   Fellowship of the Royal College of Physicians of London

(F.R.C.P.) (London)

Examinations Passed in the USA

1988   Foreign Medical Graduates Examinations in Medical Sciences (FMGEMS),

ECFMG No 052-423-1

1988   Federal Licensing Examinations (FLEX) I D No 37032350

Post Graduate Training & Professional Experience

08.1963-08.1964

House Physician & House Surgeon

Redhill General Hospital

Redhill, Surrey, England

09.1964 –10.1965

Senior House Officer – Pediatrics

Queen Mary’s Hospital for Children,

Carshalton, Surrey, England

01.1966-06 1966

Senior House Officer -Internal Medicine and Chest Disease,

Central Middlesex Hospital, London, England

01.1967-08.1969

Registrar – Internal Medicine and Neurology.

Central Middlesex Hospital, London, England

11.1969-04.1970

Senior House Officer Neurology.

National Hospital for Nervous Diseases,

Queen Square, London, England

04.1970-08.1970

Locum Registrar – Neurology.

National Hospital for Nervous Diseases,

Queen Square, London, England

08.1970-08.1987

Assistant & later Associate Professor of Neurology.

University of Tehran, Tehran, Iran

10.1981-04.1982

Honorary Clinical Assistant.

National Hospital for Nervous Diseases,

Queen Square, London, England

08.1970-08 1987

Head of Department of Internal Medicine & Chief of Department of Neurology.

Shariati Hospital, University of Tehran,

Tehran, Iran

08.1987-04.1990

Research Associate and Associate Director.

Cerebral Blood Flow Laboratory, Department of Neurology, Veterans Administration Medical Center,

Houston, Texas, USA.

04.1990-04.1994

Neurologist.

St. Luke’s Episcopal Hospital,

Houston, Texas, USA.

08.1990-04.1994

Clinical Assistant Professor of Neurology.

Baylor College of Medicine, Houston, Texas, USA.

1994 – Present

Professor of Neurology.

University of Tehran, Tehran, Iran.

Professional Society Memberships

Full Medical Registration (since 1964)

Permanent Medical Registrar, General Medical Council, England (Reg. No. 0465494)

Member       Royal College of Surgeons, England

Fellow          Royal Society of Medicine, London (No. 0187814)

Fellow          Royal College of Physicians, London

Associate     Clinical Member  American Academy of Neurology

Member       Texas Medical Association

Member       Harris County Medical Society

Member       Houston Neurological Society

Member       Association of British Neurologists

President     Iranian Multiple Sclerosis Society

Licenser

Iranian Medical Council, License No. 9258. (1970)

Texas State Board, License No. H. 67741. (1989)

The University of the State of New York, License No. 181470. (1990)

Certificates

21st July 1987       Certificate of Good Standing. General Medical Council, England.

Consultant Appointments & Hospital Privileges

St Luke’s Episcopal Hospital, Houston, Texas, USA.

Methodist Hospital, Houston ,Texas, USA.

Veterans Administration Medical Center, Houston, Texas, USA.

Metagorda General Hospital, Bay City, Texas, USA.

Herman Hospital, Houston, Texas, USA.

Consultant Physician Jam General Hospital, Tehran, Iran.

Teaching Appointments

Preceptor Instructor- Baylor College of Medicine, Houston, Texas, USA.

Instructor- University of Tehran, Dr. Shariati Medical Center, Tehran,   Iran

Instructor- Free University of Iran, Tehran, Iran

Examiner- Iranian Board of Neurology, Tehran, Iran.

Expert- Iranian Medical Council, Tehran, Iran.

Presentations

1.  Lotfi J., Derakhshan J.

A clinical neurological syndrome not fully described in English

Literature (abstract). Eighth Pahlavi Medical Congress, Shiraz, Iran, May 1977

2  Lotfi J., Massoud M

Study of the cell mediated immunity in multiple sclerosis in Iran (abstract)

Proceedings of the 11th World Congress of Neurology,

Amsterdam, Holland, September 1977

3. Lotfi J., Nikbin B.

Histocompatibility antigens in multiple sclerosis in Iran (abstract)

Proceedings of the 11th World Congress of Neurology,

Amsterdam, Holland, September 1977

4. Lotfi J.

Subacute sclerosing panencephalitis in Iran (abstract)

Proceedings of the 11th World Congress of Neurology,

Amsterdam, Holland, September 1977

5.  Lotfi J., Massoud M.

Lymphocyte stimulation with measles antigen in Iran. (abstract)

Ninth Pahlavi Medical Congress, Shiraz, Iran, May 1978.

6.  Lotfi J., Forouzanfar M., Massoud M.

Cell mediated immunity and lymphocyte subpopulation studies in thymectomized and non-thymectomized patients with myasthenia gravis. (abstract)

4th International Congress on Neuromuscular Diseases .Montreal, Canada, September 1978

7. Lotfi J., Nikbin B.

Chemotaxis and random motility in thymectomized and non-thymectomized patients with myasthenia gravis (abstract)

4th International Congress on Neuromuscular Diseases. Montreal, Canada, September 1978

8. Lotfi J., Nikbin B.

Humoral immunity in thymectomized and non- thymectomized patients with myasthenia gravis (abstract)

4th International Congress on Neuromuscular Diseases. Montreal, Canada, September 1978

9. Lotfi J., Nikbin B.

DRW antigen in multiple sclerosis in Iran. (abstract) Excerpa Medical Publications Twelfth World Congress of Neurology, , Kyoto, Japan , September 1981

10.  Lotfi J., Nikbin B., Massoud M.

Lymphocyte subpopulation in myasthenia in Iran. (abstract) Excerpa Medical Publications

Twelfth World Congress of Neurology, , Kyoto, Japan, September 1981

11.  Lotfi J.

Transfer factor in the treatment of subacute sclerosing panencephalitis (abstract) Excerpa Medical Publications.

Twelfth World Congress of Neurology, Kyoto, Japan September 1981

12.  Lotfi J., Anaraki F.

Transfer factor in the treatment of subacute sclerosing panencephalitis (abstract), Sixth Asian and Oceanian Congress of Neurology, Taipai, Republic of China , 1983

13.  Lotfi J.

Multiple sclerosis in Iran (abstract) Thirteenth World Congress of Neurology, Neurology, Hamburg, West Germany, 1985

14.  Lotfi J., Hakami A:

Myasthenia Gravis in Iran: Report of the effects of thymectomy in 50 cases (abstract) Sixth International Congress of Neuromuscular Diseases, Los Angeles, California, USA, July 1986

15.  Lotfi J., Pourmahmoudian H.

Hereditary mutilating sensory neuropathy with pyramidal tract signs, American Academy of Neurology, 40th  Annual Meeting, Cincinnati, Ohio, USA 1988

16.  Harati Y., Lotfi J.

Avicenna, facial palsy, and trigeminal neuralgia, American Academy of Neurology, 41st Annual Meeting, Chicago, Illinois, USA 1989

17.  Lotfi J., Pourmahmoudian H.

Neurological manifestation of hypoparathyroidism in 28 patients (abstract) Fourteenth World Congress of Neurology, New Delhi, India 1989

18.  Pourmahmoudian H., Lotfi J.

Thymic pathology in 69 generalized myasthenia gravis patients.

(abstract) Journal of the Neurological Sciences, Volume 98 Page 300 (Supplement) September 1990

Seventh International Congress of Neuromuscular Diseases , Munich, Federal Republic of Germany , September 1990

19.  Mortel KF., Lotfi J., Meyer JS., Funk J.

Long-term Clinical outcome in normal volunteers and patients with Cerebral transient Ischemic attacks.

American Neurological Association, 16th  Annual Meeting, Seattle, Wash., USA 1991

20.  Lotfi J., Sikaroodi H.

Botulinum Toxin for Dystonia in Iranian patients.

1st International Symposium on Medical News. Tehran, Iran October 1999

21.  Lotfi J., Ghaem Maghami AB. et al

Avicenna and Trigeminal Neuralgia

Neurology 54, (Supplement 3)

Tehran Conference on Neurology, Tehran, Iran April 2000

22. Lotfi J., Noroozian M.

Higher Achievement of Left Handers.

Proc. Aust. N. Neuroscience Soc. Vol. II.

12th Annual Meeting Society Australian Neuroscience Society 2000

23.  Lotfi J., Soltanzadeh A.

Olfactory Dysfunction in Parkinson’s Disease

XVII World Congress of Neurology, London, UK, June 2001

24.  Lotfi J., Zamani B.

History of Neurology in Iran

XVII World Congress of Neurology, London, UK, June 2001

25.  Lotfi J.,.Fazel M. et al

Carotid Endarterectomy in Iran

Journal of Neurology. Vol. 249, (Supplement l), June 2002

European Neurological Society, Berlin, Germany, June 2002

26.  Lotfi J., Nafisi N.

Subarachnoid hemorrhage in Iran

European Federation of Neurological Societies, Helsinki, Finland August 2003

27.  Lotfi J., Adibnejad S.

1. Complication of Interferon Therapy in Multiple Sclerosis

2. European Committee for Treatment and Research in Multiple Sclerosis

ECTRIMS 2003 Milan, Italy, 2003

28.  Lotfi J., Nabavi M.

A Study of Multiple Sclerosis in 203 patients.

Multiple Sclerosis Vol.9.

ECTRIMS 2003, Milan, Italy, September 2003

29. Lotfi J.

Changing Multiple Sclerosis: Epidemiology in Iran

MS Forum: MS Across Continents.

Insights from Asia and the Middle East. Bangkok, Thailand. 2003.

30. Lotfi J.

Multiple Sclerosis in Children

Regional MS Forum, Beirut, Lebanon. February 2004

31. Lotfi J.

1. Side effects of Interferon Beta in MS

Journal of Neurology, Vol.251 (Supplement 3) Page 164

2. Botulinum Toxin in Migraine

Journal of Neurology, Vol.251 (Supplement 3) Page 144

14th ENS Barcelona, Spain. June 2004.

32. Lotfi J.

1. Clinical Course evaluation of patients and progression of MS treated with Novatrone.

2. Measurement of antibodies to Interferon Beta in Iranian MS patients

3. Report on 325 patients with MS in Iran

8th EFNS Paris, France. September 2004.

33. Lotfi J.

Study of 1714 Iranian MS patients

ECTRIMS 2004, Vienna, Austria. October 2004

34. Lotfi J.

MS in Adolescents & Children

MS Across Continents: Changing knowledge of MS in Asia.

Ho Chi Minh City, Vietnam November 2004

35.   Lotfi J.

Epidemiology of MS in Iran: Redefining efficacy

International Speech given on the Epidemiology of Ms in Iran.

Kuwait City, Kuwait. December 2004

36.   Lotfi J.

1. Mesenchymal stem cells in the treatment of Multiple Sclerosis.

*Short listed for a prize

2. Is Multiple Sclerosis increasing in Iran? Gathering the ideas.

3. 20 years of experience in Wilson’s Disease.

Journal of Neurology. 252 (Supplement 2)

15th ENS 2005 Vienna, Austria. June 2005

37.   Lotfi J.

1. MS in Iran.

2. Cognitive Dysfunction in Multiple Sclerosis.

European J of N., Vol.12, (Supplement 2) Page 135.

Symposium on Effective MS Therapy Istanbul, Turkey September 2005

38.   Lotfi J.

Cognitive Dysfunction in Multiple Sclerosis

9th EFNS Athens, Greece. September 2005

39.   Lotfi J.

1. Childhood and Juvenile MS: Report on 150 cases.

2. Short & Long Term Perception in MS: Evidence for a behavioral shift.

Multiple Sclerosis Vol. 11, Supplement 1 Page 573.

21st ECTRIMS/ACTRIMS 2005 Thessaloniki, Greece September 2005

40.   Lotfi J., Talebani

1. Mesenchymal stem cell in MS.

2. Association of Microchimerism and MS

J. of the Neurological Sciences, Vol.238 (Supplement 1) Page 231

WCN Sydney, Australia November 2005

41.  Lotfi J.

Application of McDonald Criteria in non-classical Multiple Sclerosis

MS Across Continents: Advances in the knowledge of MS in Asia.

Sydney, Australia November 2005

42. Lotfi. J.

Side Effects of Interferon in Multiple Sclerosis

ECTRIMS, Madrid, Spain September 2006

International Medical Publications

1.  Faghihi-Shirazi F., Lotfi J., et al:

The pathogenesis of Potts Paraplegia and the effect of surgical intervention in it’s course of prognosis. Acta Medica Iranica 20 Pages 93-105. 1997.

2.  Mirchamsey H., Abbassioun K., Lotfi J , et al:

Isolation & characterization of a defective measles virus from patients’ brain biopsies with subacute sclerosing panencephalitis. Intervirology 9: Pages 106-108. 1978

3. Lotfi J., Nikbin B., Derakhshan I., et al:

Histocompatibility antigens (HLA) in Multiple Sclerosis in Iran.

J Neurosurgy Psychiatry 41:Pages 699-701. 1978

4.  Derakhshan I , Lotfi J , Abbassioun K

Degenerative progressive myoclinic epilepsy:electrokymographic observations.

Can J Neuro Sci 6 (No 1) Pages 65-68. 1979

5.  Derakhshan I., Lotfi J., Kaufman B.:

Ophthalmoplegia, ataxia, and hyperreflexia (Fisher Syndrome)

European Neurology 18: Pages 361-366. 1979

6.  Derakhshan I., Shafyi A., Lotfi J., Scillian JJ.:

An unusual form of measles meningoencephallitis. J Neuro 221:Pages 169-198. 1979.

7.  Derakhshan I., Sabbouri M., Lotfi J.,:

Holoprosencephaly, computed tomography and pneumoencephalograhic finding with anatomical correlation. Arch Neurol 37: Pages 55-57. 1980

8.  Lotfi J., Derakhshan I.:

Subacute sclerosing panencephalitis in Iran.

Iranian Journal of Medical Sciences 11:Pages 97-110. 1980

9.  Massoud A., Lotfi J., et al :

Lymphocytes subpopulation and cell mediated immunity in multiple sclerosis in Iran. Acta Medica Iranica 22(No.3).Pages 195-208.1980.

10.  Derakhshan I., Massoud A., Froozanfar N., Nikbin B., Lotfi J.:

Subacute sclerosing panencephalitis in Iran: Clinical and Immunological study of 23 patients. Neurology ( NY) 31:1Pages 77-180. 1981.

11.  Lotfi J., Derakhshan I., Abbassioun K., Mirchamsey H.:

Subacute sclerosing panencephalitis in Iran: Clinical and Immunological characterization. Proceedings of the First International Symposium on SSPE, Haddad FS, Matossian R (Eds) Bouheiry Bros. Press, Beirut, Lebanon. 1983

12. Anaraki F., Tabatabaiyan A., Lotfi J.:

Immunological features in subacute slerosing panencephalitis treated with transfer factor. Proceedings of the First International Symposium on SSPE, Haddad FS, Matossian R (Eds) Bouheiry Bros. Press, Beirut, Lebanon. 1983

13.  Shafyi A., Lotfi J., Mirchamsey H.:

Subacute sclerosing panencephalitis in Iran. Kitassato Arch Exp Med (Japan) 57(No.4). December 1984

14.  Lotfi J , Meyer JS.:

Cerebral hemodynamic and metabolic effects of chronic alcoholism.

Cerebrovascular and Brain Metabolism Reviews 1:Pages 2-25. 1989.

15.  Meyer J., Rogers R., McClintic K., Mortel KF., Lotfi J.:

Randomized clinical trial of daily aspirin therapy in multi- infarct Dementia JAGS 37: Pages 549-555. 1989

16.  Meyer JS., Lotfi J.:

Vascular and multi-infarct dementia demography, risk factors, prevention, and treatment. Neurology in Europe I , Bariko F, Gerstenbrand F, Turcani P (Eds), John Lybbey & Co Ltd., Pages:109-114. 1989

17.  Meyer J., Lotfi J., Kobari M.:

Treatment of migraine and cluster headache with calcium antagonists. Cerebral Ischemia and Calcium, Hartman A., Kuschinski W.(Eds), Springer-Verlag, Berlin & Heidelberg. Pages 410-418. 1989

18.  Meyer JS., Lotfi J., Martinez G., Caroselli JS., Mortel KF., Thornby JI.:

Effects of medical and surgical treatment on cerebral perfusion and cognition in patients with chronic ischemia. Surg Neurol 34:Pages 301-308. 1990

19.  Lotfi J.:

Abu-Ail Sina and the description of Terigeminal Neuralgia. Acta Medica Iranica, Vol. 34, Pages 55-60. 1996

20.  Lotfi J.:

Long term clinical outcome in normal volunteers and patients with transient ischemic attack. Acta Medica Iranica , 37(1):Pages 49-51. 1999

21.  Ale-yassin H., Lotfi J., et al:

Multiple sclerosis: A study of 318 patients. Arch Iran Med, 5 (1) Pages 24-27. 2002

22.  Noroozian M., Lotfi J.:

Academic Achievement & Learning Abilities in Left-handers.

Cortex 38 Pages 779-785. 2002.

23. Sanati A., Lotfi J., et al:

Lack of association between Leber’s Optic Atrophy and Multiple Sclerosis European Neurology 51 Pages 68-71. 2004:

24. Izad, Vodjgani, Lotfi, et al:

Interferon Gamma Gene Polymorphism in Iranian patients with MS.

Iranian Journal of Allergy, Asthma, & Immunology Vol. 3, No.3, September 2004

25. Lotfi J., Meftapoor M., Sharasbi AA., et al:

Novatrone treatment in Multiple Sclerosis.

Iranian Journal of the Faculty of Medicine 62 No.10 Pages 815 –820. 2005.